Genprex Ebitda from 2010 to 2025

GNPX Stock  USD 0.35  0.03  7.89%   
Genprex EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2025. During the period from 2010 to 2025, Genprex EBITDA regression line of annual values had r-squared of  0.87 and arithmetic mean of (11,548,738). View All Fundamentals
 
EBITDA  
First Reported
2016-03-31
Previous Quarter
-6.5 M
Current Value
-4.3 M
Quarterly Volatility
2.5 M
 
Yuan Drop
 
Covid
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.85. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
  
Check out the analysis of Genprex Correlation against competitors.
For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Latest Genprex's Ebitda Growth Pattern

Below is the plot of the Ebitda of Genprex over the last few years. It is Genprex's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Genprex Ebitda Regression Statistics

Arithmetic Mean(11,548,738)
Geometric Mean5,411,023
Coefficient Of Variation(98.28)
Mean Deviation9,931,335
Median(4,131,297)
Standard Deviation11,350,194
Sample Variance128.8T
Range30M
R-Value(0.94)
Mean Square Error17.3T
R-Squared0.87
Slope(2,229,987)
Total Sum of Squares1932.4T

Genprex Ebitda History

2025-26.6 M
2024-28 M
2023-31.1 M
2022-23.8 M
2021-20.6 M
2020-17.9 M
2019-10.6 M

About Genprex Financial Statements

Genprex investors use historical fundamental indicators, such as Genprex's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-28 M-26.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.